SCHEMBL21276535

SCHEMBL21276535

C[C@H]1CC(O)=CCN1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.39
SETD7 Q8WTS6 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
HSD11B1 P28845 1/20 0.34
NPC1 O15118 1/20 0.34
MAP4K4 O95819 1/20 0.34
GPR119 Q8TDV5 1/20 0.34
PREP P48147 1/20 0.34
ESR2 Q92731 1/20 0.34
GRM5 P41594 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31457954 0.81 GPR119 (0.35) MAPK1SETD7CHRM2CHRM1CHRM3
SCHEMBL12489284 0.78 USP2 (0.36) SETD7MAP4K4GPR119MEN1KMT2A
SCHEMBL24700152 0.77 GRM5 (0.42) GPR119GRM5
SCHEMBL25166115 0.76 PREP (0.36) CHRM2CHRM1CHRM3NPC1GPR119
SCHEMBL5758623 0.76 HSD11B1 (0.35) HSD11B1GPR119MEN1KMT2A
SCHEMBL23868537 0.75 GRM1 (0.45) SETD7GPR119GRM5
SCHEMBL24186458 0.74 USP30 (0.38) MAPK1SETD7MAP4K4MEN1KMT2A
SCHEMBL20442937 0.74 USP30 (0.38) MAPK1SETD7MAP4K4MEN1KMT2A
SCHEMBL21326425 0.74 USP30 (0.38) MAPK1SETD7MAP4K4MEN1KMT2A
SCHEMBL16041277 0.74 NR1H2 (0.35) SETD7HSD11B1GPR119MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10385036-B2 Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof PFIZER INC. (US) 2019-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10385036-B2 Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof RORC, RORB, RORA MAPK1 3539/4885SETD7 2844/4885CHRM2 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.